secwatch.observer — SEC 8-K summary
======================================

Issuer:     Lunai Bioworks Inc. (LNAI)
CIK:        0001527728
Form:       8-K
Filed at:   2025-02-19T23:59:59+00:00
Accession:  0001731122-25-000248
Event type: other_material
Sentiment:  negative
Materiality: 0.85
Item codes: 4.02
LLM model:  deepseek-v4-flash:cloud@v2

Renovaro restates multiple prior financials due to warrant accounting error
---------------------------------------------------------------------------

- Audit Committee determined misstatements in Q3 FY2024, FY2024, and Q1 FY2025 filings over warrant exercises in March 2024.
- Warrant exercises were not properly reflected as change in fair value of contingent consideration.
- Company will amend the three filings as soon as practicable; prior reports should no longer be relied upon.
- Restatement affects unaudited interim and audited annual consolidated financial statements.
- Non-reliance extends to related press releases, shareholder communications, and investor presentations.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1527728/000173112225000248/0001731122-25-000248-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1527728/000173112225000248/e6373_8k.htm
  HTML page:      https://secwatch.observer/filing/0001731122-25-000248

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer